From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 3, p. 8
- Publication type:
- Article
Works matching IS 10685308 AND DT 2011 AND VI 22 AND IP 3
Results: 10
1
2
Hallucinations and delusions in a citalopram-treated active-duty serviceman.
- Published in:
- 2011
- Publication type:
- Case Study
3
Adjunctive sildenafil for negative symptoms of schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 3, p. 8
- Publication type:
- Article
4
Antidepressant use in pregnancy linked to increased pathology.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 3, p. 7
- Publication type:
- Article
5
Metabolic side effects of atypical antipsychotics.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 3, p. 7
- Publication type:
- Article
6
Olanzapine for relapse prevention of manic episodes in BD.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 3, p. 4
- Publication type:
- Article
7
Cognitive therapy for depression relapse prevention.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 3, p. 3
- Publication type:
- Article
8
Serotonin syndrome linked to concurrent ziprasidone and an MAOI.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
9
Numerous factors cited to explain time-lag bias for negative trials.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 3, p. 1
- Publication type:
- Article
10
Study of venlafaxine XR for GAD shows benefit of long-term drug use.
- Published in:
- Brown University Psychopharmacology Update, 2011, v. 22, n. 3, p. 1
- Publication type:
- Article